13F HOLDINGS REPORT
Decheng Capital LLC
Quarter ended Q4 2024 · Filed February 14, 2025 · Accession 0001104659-25-013870
Total Value
$466.2M
Positions
28
Other Managers
0
Confidential Omitted
No
Holdings (28)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CG ONCOLOGY INC | CGON | 6,371,669 | $182.7M | 39.20% |
| 2 | Nuvation Bio Inc. | NUVB | 25,954,439 | $69.0M | 14.81% |
| 3 | Upstream Bio Inc. | UPB | 3,285,293 | $54.0M | 11.58% |
| 4 | NEWAMSTERDAM PHARMA CO NV | NAMSW | 770,000 | $19.8M | 4.24% |
| 5 | Illumnia, Inc. | ILMN | 94,767 | $12.7M | 2.72% |
| 6 | Arcus Biosciences, Inc | RCUS | 808,789 | $12.0M | 2.58% |
| 7 | KRYSTAL BIOTECH INC | KRYS | 76,772 | $12.0M | 2.58% |
| 8 | REVOLUTION MEDICINES INC(NSM) | RVMDW | 226,000 | $9.9M | 2.12% |
| 9 | MOONLAKE IMMUNOTHERAPEUTICS | MLTX | 171,600 | $9.3M | 1.99% |
| 10 | CRINETICS PHARMACEUTICALS IN | CRNX | 167,958 | $8.6M | 1.84% |
| 11 | BeyondSpring Inc. | BYSI | 4,882,651 | $8.0M | 1.71% |
| 12 | MERUS NV | N5749R100 | 189,098 | $8.0M | 1.71% |
| 13 | Lyell Immunopharma, Inc. | LYEL | 11,909,341 | $7.6M | 1.63% |
| 14 | Zentalis Pharmaceuticals Inc. | ZNTL | 2,338,095 | $7.1M | 1.52% |
| 15 | ARCELLX INC | ACLX | 84,377 | $6.5M | 1.39% |
| 16 | PHATHOM PHARMACEUTICALS INC | PHAT | 694,254 | $5.6M | 1.21% |
| 17 | Aclaris Therapeutics, Inc. | ACRS | 2,266,667 | $5.6M | 1.21% |
| 18 | LEGEND BIOTECH CORP-ADR | LEGN | 153,558 | $5.0M | 1.07% |
| 19 | CYTOKINETICS INC | CYTK | 100,000 | $4.7M | 1.01% |
| 20 | Biontech SE-ADR | BNTX | 40,000 | $4.6M | 0.98% |
| 21 | Aura Biosciences, Inc. | AURA | 515,555 | $4.2M | 0.91% |
| 22 | Equillium Inc. | EQ | 4,447,308 | $3.3M | 0.71% |
| 23 | 4D MOLECULAR THERAPEUTICS IN | FDMT | 400,000 | $2.2M | 0.48% |
| 24 | VERA THERAPEUTICS INC | VERA | 49,767 | $2.1M | 0.45% |
| 25 | AtriCure Inc. | ATRC | 26,797 | $818,916 | 0.18% |
| 26 | Pyxis Oncology, Inc (formerly Apexigen) | PYXS | 326,810 | $509,824 | 0.11% |
| 27 | GRAIL INC | GRAL | 9,684 | $172,859 | 0.04% |
| 28 | Nuvation Bio Inc. | NUVB | 646,057 | $148,593 | 0.03% |